1 -DEA Fact Sheet. Washington, DC: Drug Enforcement Administration, Office; of Public Affairs; December 2012. Available at: http://www.justice.gov/dea/docs/1207_factsheet.pdf. Accessed February 20, 2013.
2 -Title 21United States Code Controlled Substances Act, Part B -- Authority to Control; Standards and Schedules, Section 811. Authority and Criteria for Classification of Substances . Available at: http://www.deadiversion.usdoj.gov/21cfr/21usc/811.htm. Accessed February 20, 2013.
3 -Hydrocodone. Rockville, MD: Office of Diversion Control, Drug Enforcement Administration; June 2011. Available at: http://www.deadiversion.usdoj.gov/drugs_concern/hydrocodone.pdf. Accessed March 19, 2013.
4 -U.S. Drug Enforcement Administration, Office of Diversion Control. (2011). National Forensic Laboratory Information System: 2011 Annual Report. Springfield, VA: U.S. Drug Enforcement Administration. Available at: http://www.deadiversion.usdoj.gov/nflis/2011annual_rpt.pdf. Accessed February 11, 2013.
5 -Fiore C. Vicodin triggers interagency war. MedPage. December 22, 2012: Available at: http://www.medpagetoday.com/PublicHealthPolicy/HealthPolicy/36593. Accessed March 19, 2013.
6 -Gov. Beshear Signs HB 217, makes common sense improvements to landmark prescription drug abuse bill. Communications Office. March 05, 2013. Available at: http://migration.kentucky.gov/newsroom/governor/20130305hb217.htm. Accessed March 10. 2013.
7 -Kuehn, BM. FDA committee: more restrictions needed on hydrocodone combination products. JAMA. 2013; 309(9):862.
8 -A.G. Schneiderman alerts medical professionals to new hydrocodone rule change under Rx drug law. Press release 2/27/2013. Available at: http://www.ag.ny.gov/press-release/ag-schneiderman-alerts-medical-professionals-newhydrocodone-rule-change-under-rx-drug . Accessed March10, 2013.
9 -Kuehn BM. FDA Committee: More Restrictions Needed on Hydrocodone Combination Products JAMA, March 6, 2013; 309(9): 362.